DEF 14AThe Ballot
Theravance Biopharma, Inc. files DEF 14A
Filed Mar 25, 2016 · 10y ago · Accession 0001047469-16-011603
Plain English
Proxy statement — executive pay, board nominees, and shareholder votes.
Read the source below for the full document.
Filing details
- Company
- Theravance Biopharma, Inc.
- Ticker
- TBPH
- CIK
- 1583107
- Form type
- DEF 14A
- Filing date
- Mar 25, 2016
- Report date
- May 3, 2016
- Document
- a2227981zdef14a.htm
- Size
- 842 KB